Abstract:
본 발명은 경단구슬모자반 추출물로부터 분리한 유효물질인 3-베타-하이드록시-5 알파, 6 알파-에폭시-7-메카스틱멘-9-원을 이용한 알러지성 질환의 개선제 조성물을 개시한다. 상기 유효물질은 탈과립 억제 활성, 사이토카인의 생성 억제 활성, p-AKT의 생성 억제 활성 등을 가지고 있다.
Abstract:
본 발명은 좁은잎천선과로부터 분리한 활성물질인 블라디놀 F를 이용한 항염증성 조성물을 개시한다. 상기 활성물질인 블라디놀 F는 NO 생성 억제 활성, PGE 2 생성 억제 활성 및 염증성 사이토카인(TNF-α, IL-1β 및 IL-6)의 생성 억제 활성을 갖는다.
Abstract:
본 발명은 참그물바탕말을 이용한 피부 외용제 조성물을 개시한다. 구체적으로 본 발명은 피부 세균인 스타필로코쿠스 아우레우스 , 스타필로코쿠스 에피더미디스 및 프로피오니박테리움 아크네에 대해 항균 활성을 갖고 섬유아세포의 콜라겐 생성 촉진 활성을 가지며 나아가 자외선 차단 활성을 가진 참그물바탕말을 이용한 피부 외용제 조성물을 개시한다.
Abstract:
The present invention relates to a method for distinguishing Epinephelus bruneu from Epinephelus septemfasciatus and a kit thereof which use a D-loop region of mitochondrial genome sequences. The method for distinguishing Epinephelus bruneu from Epinephelus septemfasciatus includes the steps of: (a) obtaining biological samples from Epinephelus bruneu and Epinephelus septemfasciatus; (b) separating mitochondrial genome DNAs of Epinephelus bruneu from mitochondrial genome DNAs of Epinephelus septemfasciatus; (c) amplifying the D-loop region of genome DNAs; and (d) identifying the length of an amplified product.
Abstract:
The present invention discloses an anti-infammatory composition using vladinol F which is an active substance isolated from Ficus erecta var. sieboldii King. The vladinol F which is an active substance has inhibitory activities against the generation of NO, the generation of PGE2, and the generation of inflammatory cytokines (TNF-α, IL-1β and IL-6).
Abstract:
The present invention discloses a skin whitening composition using cheesewood leaf extract, cheesewood fruit extract, ginseng Monascus fermented product, ginseng yeast fermented product, red ginseng Monascus fermented product or red ginseng yeast fermented product, which have an inhibitory activity on the generation of melanin when treated in B16F10, which is a melanoma cell stimulated by α-MSH, which is a melanocyte stimulator.
Abstract:
The present invention discloses a composition for improving liver function. In particular, the composition for improving liver function reduces activity of GPT and GOT, indicator enzymes of liver dysfunction, in the blood in alcohol and non-alcohol animal experiment models. The composition for improving liver function uses a wild orange leaf extract, a whole Sargassum muticum extract, a Quercus acuta leaf extract, a mixed extract of Pittosporum tobira leaf and fruit, a whole Acorus gramineus extract, a whole Gelidium amansii extract, a whole ginseng flower extract, ginseng fermented by yeast, and red ginseng fermented by yeast.